[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.179.146. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Invited Critique
September 2010

The Changing Face of Pheochromocytoma: Varied Presentations, Better OutcomesComment on “One Hundred Two Patients With Pheochromocytoma Treated at a Single Institution Since the Introduction of Laparoscopic Adrenalectomy”

Author Affiliations

Author Affiliation: Endocrine Surgical Unit, Department of Surgery, David Geffen School of Medicine at University of California, Los Angeles.

Arch Surg. 2010;145(9):897-898. doi:10.1001/archsurg.2010.160

The report by Shen and associates from University of California, San Francisco is one of the largest single-institution experiences in pheochromocytoma ever published. They describe a great diversity in the initial clinical manifestations encountered, with only a minority of patients presenting electively with classic signs and symptoms. The growing fraction of patients identified through incidental radiographic findings and known familial syndromes reflects the changing face of this disease and our increasing understanding of genotype-phenotype correlations. The fact that 14 patients presented in overt hemodynamic crisis likely reflects selective referral of high-risk patients to this established center of expertise. The 4 patients who required intra-aortic balloon counterpulsation are a reminder that pheochromocytoma can present with refractory cardiogenic shock. Despite these challenges, Shen and associates achieved a zero mortality rate in their series. Their work adds to the existing literature demonstrating that laparoscopic adrenalectomy is the procedure of choice for the treatment of pheochromocytoma.

First Page Preview View Large
First page PDF preview
First page PDF preview
×